Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Optimal stimulation toward the dermal papilla lineage can be promoted by combined use of osteogenic and adipogenic inducers

Kazi T., Niibe I., Nishikawa A., Matsuzaki T.

Animal Study on Hair Regeneration, published in FEBS Open Bio (2020) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
FEBS Open Bio (2020)
Reported sample size
—
Source database
Europe PMC
PMID
31730301
PMCID
PMC6996385
DOI
10.1002/2211-5463.12763
Citations
5

Abstract (original English)

Dermal papilla cells (DPCs) play crucial roles in hair regeneration, but they readily lose their hair-forming ability during in vitro culture. Although the formation of spheroids partially restores the ability, shrinkage of the spheroids makes it difficult to maintain cellular viability. To address this problem, we stimulated DPCs with factors known to induce adipogenic and/or osteogenic differentiation, because DPCs share unique gene expression profiles with adipocytes and osteocytes. We isolated DPCs from versican (vcan)-GFP mice, in which GFP is expressed under the control of a vcan promoter, which is strongly active in DPCs of anagen hair follicles. GFP fluorescence was most intense when the spheroids were made from DPCs cultured in a half-diluted combination of adipogenic and osteogenic media (CAO1/2), a Dulbecco's modified Eagle's medium-based medium that contains 10% FBS, 275 nm dexamethasone, 2.5 mm β-glycerol phosphate, 12.5 µg·mL -1 ascorbic acid, 0.125 µm isobutylmethylxanthine and 2.5 ng·mL -1 insulin. The dose of each additive used was less than the optimal dose for adipogenic or osteogenic differentiation, and shrinkage of the spheroids was avoided through the addition of fibroblast growth factor 2 and platelet-derived growth factor-AA to CAO1/2. In addition, the gene and protein expression of vcan, osteopontin, alkaline phosphatase and α-smooth muscle actin in th

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Hair FollicleCells, CulturedOsteocytesAnimalsMicePlatelet-Derived Growth FactorCell DifferentiationOsteogenesisAdipogenesisPrimary Cell Culture

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research